Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Increase in S-Shares by Controlling Shareholder

Issuer & Securities

Issuer/ Manager
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities
TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
Date &Time of Broadcast
05-Feb-2026 20:23:04
Status
New
Announcement Sub Title
Increase in S-Shares by Controlling Shareholder
Announcement Reference
SG260205OTHR4CBY
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
ANNOUNCEMENT ON THE INCREASE IN SHAREHOLDING OF S-SHARES OF THE COMPANY BY THE CONTROLLING SHAREHOLDER

Additional Details

Person(s) giving notice
Substantial Shareholder(s)/Unitholder(s) (Form 3)
Date of receipt of notice by Listed Issuer
05/02/2026

Attachments

05.02.2026 eFORM3-TPH_Guoyu_Guoxin_Bohai Assets Management_Tsinlien_TEDA Investment.pdf
if you are unable to view the above file, please click the link below.
_05.02.2026 eFORM3-TPH_Guoyu_Guoxin_Bohai Assets Management_Tsinlien_TEDA Investment.pdf
Total size =238K